What are the common symptoms of hepatocellular carcinoma?
Common symptoms of hepatocellular carcinoma include abdominal pain or swelling, weight loss, loss of appetite, jaundice (yellowing of the skin and eyes), and fatigue. Some individuals may also experience nausea, vomiting, or an enlarged liver.
What are the risk factors for developing hepatocellular carcinoma?
Risk factors for hepatocellular carcinoma include chronic hepatitis B or C infection, cirrhosis from any cause, heavy alcohol consumption, nonalcoholic fatty liver disease, aflatoxin exposure, obesity, type 2 diabetes, and genetic liver disorders such as hemochromatosis.
What are the treatment options for hepatocellular carcinoma?
Treatment options for hepatocellular carcinoma include surgical resection, liver transplantation, locoregional therapies (such as radiofrequency ablation and transarterial chemoembolization), and systemic therapies such as targeted therapy with sorafenib or lenvatinib, and immunotherapy with agents like atezolizumab and bevacizumab. The choice of treatment depends on the stage of the cancer and patient-specific factors.
How is hepatocellular carcinoma diagnosed?
Hepatocellular carcinoma is diagnosed through a combination of imaging tests such as ultrasound, CT, or MRI scans, and blood tests for liver function and tumor markers like alpha-fetoprotein (AFP). If needed, a liver biopsy may be performed to confirm the diagnosis.
What is the prognosis for someone diagnosed with hepatocellular carcinoma?
The prognosis for hepatocellular carcinoma is generally poor, with a 5-year survival rate of around 18%. Early-stage diagnosis and treatment can improve outcomes, but the prognosis depends significantly on factors like tumor size, liver function, and treatment options. Advanced stages and underlying liver conditions worsen the outlook.